Objectifs d’apprentissage

À la fin de la réunion annuelle 2026 de la SCR, les participants seront en mesure:

1

Passer en revue les avancées actuelles dans la prise en charge médicale des maladies rétiniennes, y compris les nouvelles thérapies pharmacologiques et les stratégies thérapeutiques en constante évolution pour la dégénérescence maculaire liée à l'âge, l'œdème maculaire diabétique et l'occlusion veineuse rétinienne.

2

Interpréter l'imagerie rétinienne avancée et les biomarqueurs cliniques afin d'améliorer la précision du diagnostic, la surveillance de la maladie et la prise de décision thérapeutique.

3

Discuter des techniques chirurgicales contemporaines et de la prise de décision clinique en chirurgie vitréo-rétinienne, y compris les stratégies de prise en charge du décollement de la rétine, des trous maculaires et des affections vitréo-rétiniennes complexes.

4

Évaluer les technologies émergentes et les innovations, notamment l'intelligence artificielle, la thérapie génique et les nouvelles plateformes thérapeutiques susceptibles d'influencer la pratique clinique future en matière de rétine.

Accréditation

La présente activité est une activité d’apprentissage collectif agréée (section 1), au sens que lui donne le programme de Maintien du certificat du Collège royal des médecins et chirurgiens du Canada; elle a été approuvée par La Société canadienne d’ophtalmologie (SCO). Vous pouvez déclarer un maximum de 9 heures (les crédits sont calculés automatiquement). Les opinions et le contenu spécifiques de cet événement ne sont pas nécessairement ceux de SCO et relèvent de la seule responsabilité de l'organisateur ou des organisateurs.

Ordre Du Jour

Friday, April 17, 2026

PLENARY SESSION #1 – SURGERY I
Cinema – first floor
Co-chairs: Keyvan Koushan, MD & Bernard Hurley, MD

3:30 PMWelcome and Opening Remarks
Co-chairs: Bernard Hurley, MD; Keyvan Koushan, MD
3:40 – 4:35 PMSurgical Video Session: East vs West
Moderators: Amin Kherani, MD and David Wong, MD
4:40 – 4:50 PMCongenital Vitreoretinal Disorders
Audina Berrocal, MD
4:52 – 5:02 PMPower of Vitrectomy Cutter Biopsy
Hung-Da Chou, MD
5:02 – 5:12 PMMyopic Traction Maculopathy Surgery: A Beginner's Guide
Hung-Da Chou, MD
5:12 – 5:30 PMQ&A
6:00 PMWelcome Reception – New Fort Hall

Saturday, April 18, 2026

7:00 AMBreakfast – Princes' Gate Pre-function Area / Princes' Gate Ballroom

PLENARY SESSION #2 – ANTI-VEGF
Cinema – first floor
Moderators: Jason Noble, MD & Radha Kohly, MD, PhD

8:30 – 8:35 AMWelcome and Review of Agenda
Bernard Hurley, MD; Keyvan Koushan, MD
8:35 – 8:45 AMBiomarkers in Diabetic Macular Edema
Adrian Koh Hock Chuan, MD, MBBS
8:47 – 8:55 AMSPECTRUM: First Canadian Real‑world Outcomes with Aflibercept 8 mg in Previously Treated Diabetic Macular Edema
Keyvan Koushan, MD
8:57 – 9:05 AMLong-term Canadian Real-world Experience With Faricimab in Patients with Neovascular Age-related Macular Degeneration and Diabetic Macular Edema
Parth Shah, MD
9:06 – 9:11 AMIntroduction to Mila Oh Memorial Talk
John Chen, MD
9:13 – 9:23 AMMila Oh Memorial Talk: Battle of the Next Generation Therapies
John Kitchens, MD
9:24 – 9:32 AMAflibercept 8 mg in Retinal Vein Occlusion: Final Results from the QUASAR Study
Varun Chaudhary, MD
9:33 – 9:41 AMSPECTRUM: First Canadian Real‑world Outcomes With Aflibercept 8 mg in Previously Treated Neovascular Age-related Macular Degeneration
Raman Tuli, MD
9:42 – 9:52 AMCurrent Management of Polypoidal Choroidal Vasculopathy in 2026
Adrian Koh Hock Chuan, MD, MBBS
9:52 – 10:05 AMQ&A
10:15 ‒ 11:00 AMFor more details, click here
11:00 ‒ 11:25 AMBreak – Poster Session – Princes' Gate Pre-function Area
POSTER SESSION – Library Collection Lounge

PLENARY SESSION #3 – SURGERY II
Cinema – first floor
Moderators: Varun Chaudhary, MD & Wai-Ching Lam, MD

11:30 – 11:40 AMLamellar Macular Holes - What's Going On and What Should We Do?
David Steel, MBBS, MD(Res)
11:42 – 11:50 AMIs 20/20 Vision Good Enough? Outcomes of Complete Pars Plana Vitrectomy During IOL Exchange for Lens Opacification in Patients with Preserved Visual Acuity
Robert Gizicki, MD
11:52 AM – 12:00 PMSuprachoroidal Viscopexy for Rhegmatogenous Retinal Detachment: Two-year Safety and Efficacy Outcomes
Aurora Pecaku, MD
12:00 – 12:10 PMQ&A
12:12 – 12:20 PMPneumatic Retinopexy as a Temporizing Treatment Strategy for Retinal Detachment: A Population-based Cohort Study
Gareth Mercer, MD, PhD
12:22 – 12:30 PMVitrectomy After Successful Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment
Robert Gizicki, MD
12:32 – 12:42 PMTamponade Choice with Vitrectomy for Rhegmatogenous Retinal Detachment; Does It Make a Difference?
David Steel, MBBS, MD(Res)
12:40 – 12:50 PMQ&A
12:50 – 1:35 PMLUNCH – Princes' Gate Pre-function Area / Princes' Gate Ballroom
POSTER SESSION – Library Collection Lounge
1:35 ‒ 2:15 PMFor more details, click here

PLENARY SESSION #4 – POTPOURRI
Cinema – first floor
Moderators: Geoff Williams, MD & Shaheer Aboobaker, MD

2:25 – 2:35 PMWhat in the World is Going on in the United States?
John Kitchens, MD
2:37 – 2:45 PMIn Vivo Assessment of Peripheral Vitreous Traction with Ultra-widefield Swept-source OCT in Rhegmatogenous Retinal Detachment
Isabela Martins Melo, MD
2:47 – 2:57 PMPediatric Retina Detachment
Audina Berrocal, MD
2:57 – 3:07 PMQ&A
3:09 – 3:19 PMRetinopathy of Prematurity in 2026
Audina Berrocal, MD
3:21 – 3:29 PMComparative Outcomes of Secondary Intraocular Lens Fixation Techniques
Kirill Zaslavsky, MD
3:31 – 3:39 PMComparison of Clinical Outcomes of Sutureless Flanged Intrascleral (Yamane) and Four-point Gore-Tex Suture Techniques for Intraocular Lens Fixation
Robert Gizicki, MD
3:39 – 3:45 PMQ&A
3:50 ‒ 4:35 PMFor more details, click here
4:35 – 5:00 PMBREAK – Princes' Gate Pre-function Area / Princes' Gate Ballroom
POSTER SESSION – Library Collection Lounge
5:00 – 5:45 PMCRS Annual General Meeting
6:30 PMRECEPTION – Princes' Gate Pre-function Area
GALA – Princes' Gate Ballroom

Sunday, April 19, 2026

7:00 AMBreakfast – Princes' Gate Pre-function Area / Princes' Gate Ballroom

PLENARY SESSION #5 – AGE-RELATED MACULAR DEGENERATION
Cinema – first floor
Moderators: Amin Kherani, MD & David Maberley, MD

8:35 – 8:45 AMHow to Assess Functional Loss and Progression in Geographic Atrophy
Ursula Schmidt-Erfurth, MD
8:47 – 8:55 AMOne Year Results of a Phase 2 Pharmacodynamic Study: Subretinal Delivery of Investigational Gene Therapy Sura-vec (ABBV-RGX-314) for Neovascular Age-related Macular Degeneration
Robert Gizicki, MD
8:57 – 9:05 AMReduction in Subretinal Hyperreflective Material Volume with Faricimab vs Aflibercept 2 mg in Treatment-naïve Neovascular Age-related Macular Degeneration: A TENAYA/LUCERNE Post Hoc Analysis
Nirojini Sivachandran, MD, PhD
9:05 – 9:10 AMQ&A
9:10 – 9:20 AMHow do You Diagnose Polypoidal Choroidal Vasculopathy Without Indocyanine Green Angiography?
Adrian Koh Hock Chuan, MD, MBBS
9:22 – 9:30 AMAvacincaptad Pegol for Geographic Atrophy: 3.5-Year Results from the GATHER2 Open-label Extension Trial
Varun Chaudhary, MD
9:32 – 9:42 AMAge-related Macular Degeneration as a Complex Disease Between Atrophy and Neovascularization
Ursula Schmidt-Erfurth, MD
9:42 – 10:00 AMQ&A
10:00 – 10:30 AMBREAK – Princes' Gate Pre-function Area / Princes' Gate Ballroom
POSTER SESSION – Library Collection Lounge

PLENARY SESSION #6 – Artificial Intelligence
Cinema – first floor
Moderators: Varun Chaudhary, MD & Peter Kertes, MD

10:32 – 10:42 AMPractical Ways to Use Existing AI in Clinic
David Steel, MBBS, MD(Res)
10:44 – 10:52 AMBaseline Peripheral Vascular Leakage is Linked to Treatment Response in Patients With Central Retinal Vein Occlusion: A Pilot Study
Alan Cruess, MD
10:54 – 11:02 AMSubretinal Delivery of Investigational Sura-vec (ABBV-RGX-314) as a Gene Therapy
Shaheer Aboobaker, MD
11:04 – 11:14 AMAI as a Management Tool for Neovascular Age-related Macular Degeneration
Ursula Schmidt-Erfurth, MD
11:14 – 11:20 AMQ&A

PLENARY SESSION #7 – Surgery III
Cinema – first floor
Moderators: Keyvan Koushan, MD & Bernard Hurley, MD

11:25 – 11:35 AMHow Should We Treat Refractory Macular Holes?
David Steel, MBBS, MD(Res)
11:37 – 11:44 AMPredictors of Primary Anatomic Reattachment With Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment
Aurora Pecaku, MD
11:46 – 11:54 AMOuter Retinal Corrugations Indicate Retinal Break Status in Rhegmatogenous Retinal Detachment
Jeffrey Mah, MD
11:56 AM – 12:06 PMDouble the Adjuncts, Double the Confidence in Macular Surgery
Hung-Da Chou, MD
12:06 – 12:20 PMQ&A
12:20 PMConcluding Remarks
Bernard Hurley, MD, and Keyvan Koushan, MD
12:30 PMGRAB & GO LUNCH (LOCATED OUTSIDE CINEMA)
Please check back soon.

Affiches

  1. Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Vitreous Floaters: A Systematic Review and Meta-Analysis
    Ahmad, A; Kailani, Z; Bakar Butt, A; Tao, BK; Pandya, BU; Pereira, A; Tang, T; Popovic, M; Arjmand, P; Yan, P; Kherani, A; Kertes, P.
  2. Pregnancy-Associated Bilateral Central Retinal Vein Occlusion and Diabetic Retinopathy: A Trimester-Sensitive Approach
    Ahmad, A; Ji, P; Sivachandran, N.
  3. Real-Time Closed-Loop Simulator for Cortical Visual Prosthetics Using Neural-State Modulation
    Mouawad, A; Chen, J.
  4. Prognostic Value of Widefield Fluorescein Angiography for Systemic Immunomodulatory Therapy Initiation and Visual Acuity Outcomes in Patients with Non-Infectious Uveitis
    Pereira, A; Kherani, I; Tang, T; Al-Ghafri, M; Felfeli, T; Christakis, P; Kaplan, AJ;  Derzko-Dzulynsky, L; Yan, P; Bakshi, NK.
  5. High-Accuracy Automated Detection of Outer Retinal Tubulations on OCT Using a Deep Learning Model
    Zhang, E-R; Mouawad, A; Al-Khuzaei, S; Deud, B; Ayalon, A; Chen J.
  6. Incidence of delayed retinal tears and retinal detachments in initial uncomplicated cases of posterior vitreous detachments
    Lau, A; Zhang, E-R; Chaker, A; Zwaig, J; Chow, D; Chen J.
  7. Short-Term Outcomes of Switching to Faricimab in nAMD and DME Patients with Suboptimal Responses to Aflibercept
    Zhang, E-R; Ayalon, A; Al Ghafri, M; Kapusta, M; Lederer, DE; Galic, IJ; Chen, J.
  8. Ellipsoid Zone Loss as a Retinal Complication after Chimeric Antigen Receptor T-Cell Therapy: A Case Report
    Zhang, E-R; Lederer, DE.
  9. Increasing Subretinal Fluid over a Stable Choroidal Nevus Unmasking an Overlying Retinal Tear - A Diagnostic Pitfall: A Case Report
    Daud, F; Pandya, BU; Tang, T; Krema, H; Altomare, F; Yan, P.
  10. Visually Predictive Biomarkers on OCTA following Anti-VEGF treatment of Retinal Vein Occlusion - A Systematic Review
    King, S; Daud, F; Kowal, S; Lai, A; Loewen, D; Weng, N; Qiu, W; Nanji, K; Wahab, C ; Yan, P.
  11. Intraoperative Intraocular Pressure Management During Vitreoretinal Surgery: A Survey of Canadian Vitreoretinal Surgeons
    Ling, JYM; Cai, C; Mammo, Z; Lam, W-C.
  12. Defining Intraocular Safety Limits for Povidone-Iodine Irrigation: A Concentration- and Time-Dependent Study in Rats
    Huo, L; Cioana, M; Ware, M; Shoichet, M; Yan, P.
  13. Age-Related Choroidal Atrophy (ARCA): A Systematic Review of Multimodal Imaging, Clinical Features, and Differentiation from AMD and GA
    Lai, A; Pereira, A; Issa, M; Al Ghafri, M; Dollin, M; Hurley, B; MD FRCSC4, Jay Chhablani, J; Yan, P.
  14. Macular and Retinal Manifestations Following COVID-19 Vaccinations: A 2025 Update Systematic Review and Meta-Analysis
    Ji, PX; Krishnan, AR; Famiyeh, I-M; Ahmad, A; Sivachandran, N.
  15. Carbon Footprint of Pars Plana Vitrectomy, Pneumatic Retinopexy and Scleral Buckle for Rhegmatogenous Retinal Detachment Repair
    Moorjani, R; Loh, GK; Tennant, MTS; Kertes, PJ; Grewal, PS.
  16. A Novel Interactive Functional Vision Test to Visualize Patient-Perceived Vision in Retinal Disease: A Proof of Concept Pilot Study
    Sabour, S; Pecaku, A; Martins Melo, I; Ortin-Martinez, A; Muni, RH; P Kohly, RP.
  17. Comparative Analysis of Subretinal Fluid Characteristics in Regulated and Dysregulated Rhegmatogenous Retinal Detachment
    Sabour, S; Pecaku, A; Martins Melo,I; Karla, R; Muni, RH.
  18. High-Resolution Visualization of Posterior Vitreous Using Swept-Source OCT and Custom Software Enhancement
    Sabour, S; Pecaku, A; Martins Melo, I; Muni, RH; Wong, DT.
  19. Selective Therapeutic Response to Faricimab in a Coats’ Disease Variant with Cystoid Macular Edema
    Rotholz, T; Kim, GE; Ji, PX; Sivachandran, N.
  20. Non-Surgical Treatment of Full Thickness Macular Holes: A Systematic Review
    Miller, T; Kamali Zonouzi, S; Arjmand, P.
  21. Unexplained Vision Loss Following Silicone Oil Removal: A Systematic Review and Meta-Analysis
    Yu, P; Mofid, K; Naveed, F; Huo, L; Tao, BK; Pereira, A; Tang, T; Lam, W-C; Mandelcorn, ED; Wong, DT; Yan, P.
  22. Case Report: A Different Kind of Oil Removal
    Kherani, A.
  23. Prospective Evaluation of Choroidal Compartments and Vascularity Index in Rhegmatogenous Retinal Detachment Using Swept-Source OCT
    Pecaku, A; Martins Melo, I; Samet, S; Sabour, S; Zaman, M; Kirk, C; Mohammed, AR; Chhablani, J;  Muni, RH.
  24. Rare, and New, Causes of Tapetal-like Retinal Sheen
    Ballios, BG; Kodida, R; Zhai, Y.
  25. Early Canadian Faricimab Experience in Patients With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema Previously Treated With Bevacizumab Only
    Gizicki, R; Tuli, R; Sivachandran, N; Aboobaker, S; Ta Kim, D; Koushan, K; Levasseur, SD; McLaughlin, A; Wittenberg, L; Lee, T; Abbas, K;  Baker, J;  Aboukarr, A; Alexander, J; Park, JG.
  26. SPECTRUM: First Canadian RealWorld Outcomes With Aflibercept 8 mg in Previously Treated Neovascular Age-related Macular Degeneration
    Tuli R; Chaudhary, V; Mok, A; Soliman, K; on behalf of the SPECTRUM study investigators.  
  27. Anatomical Success and Visual Improvement After Macular Hole Repair Procedures: A Retrospective Analysis from a Canadian Ambulatory Surgery Center
    Naveed, F; Rotholz, T; Khannejad, S; Hashemi, E; Kunde, H; Hwang, K; Aksoy, U; Mohammed, AR; Aboobaker, S.
  28. Study Design and Rationale of the FARTHER Study: A Single-arm, Open-label, Multicenter Study Investigating the Switch to Faricimab in Responsive Aflibercept nAMD Patients
    Chaudhary, V; Kertes, P; Baker J.
  29. Modified Technique for Intrascleral Haptic Fixation of Posterior Intraocular Lenses
    Zarza, V; Williams, G; Olson, K; Azarcon, C; Kherani, S.
  30. Anesthetic Practices in Vitreoretinal Surgery: A Study on Retrobulbar Anesthesia and Monitored Anesthesia Care
    Ayalon, A; Zhang, E-R; Wasser, LV; La Mantia, A; Deud, B; Kapusta, MAA.
  31. Comparing NEI-VFQ-25 Scores Administered in Clinic and Online in Individuals With Vision Impairment
    Thomas, A; Thangavadivelu, L; Moniz, L; Mikhail, D; Tuli, R; Wong, DT; Qian, C; Sivachandran, N.
envelopemap-markercrossmenu